Drugs / ACT-281959
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01954615 | Oct 2011 → Mar 2012 | — | Idorsia Pharmaceuticals Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ACT-281959 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01954615 ↗ |
| Route | Oral | “single, oral dose of ACT-281959 prodrug formulation I” NCT01954615 ↗ |